DEVACELL, INC. Employee Directory

Biotechnology ResearchCalifornia, United States2-10 Employees

DevaCell is rapidly advancing a pipeline of therapeutic product candidates based on a proprietary synthetic vector engineering platform technology. Key therapeutic segments include - oncolytic cancer immunotherapy, gene therapy/gene editing and vaccines. 

Based on the transformative and proprietary ONCoat, nanoparticle-based synthetic vector platform technology, the company's lead therapeutic program is a synthetic vector based oncolytic cancer immunotherapy with multiple transgene payloads encoded into an engineered, adenovirus (Ad5) backbone, targeting solid tumors. The program is currently transitioning to IND-enabling studies, with human clinical trials anticipated to launch by year-end 2021. 

In the infectious disease segment, advancing to IND-enabling studies is an COVID-19 vaccine based on the same Ad5 backbone, engineered to express the SARSCoV19 virus spike protein.

The company's gene therapy/gene editing program is currently in discovery research with product candidates anticipated to advance to IND-enabling studies in the second half of 2021.

Find DEVACELL, INC. employees' phone numbers or email addresses

DEVACELL, INC. Global Highlights

Location
Employees

North America
6

Minus sign iconPlus sign icon
  • United States Of America
    6

DEVACELL, INC.'s Leadership

  • Stylized image of a person
    I. Y.
    Chief Executive Officer
    Phone icon
  • Stylized image of a person
    J. S.
    Chief Operating Officer
    Phone icon
  • Stylized image of a person
    M. S.
    R&d Scientist Nano Engineering
    Phone icon

Contact profiles from DEVACELL, INC.

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    I. Y.
    Chief Executive Officer
    Phone icon
    UNITED STATES
    Aug 04, 2023
  • Stylized image of a person
    J. S.
    Chief Operating Officer
    Phone icon
    Aug 15, 2025
  • Stylized image of a person
    M. S.
    R&d Scientist Nano Engineering
    Phone icon
    Apr 23, 2024

Frequently Asked Questions

What is DEVACELL, INC. known for?

Minus sign iconPlus sign icon
DEVACELL, INC. was founded in 2015 operates in the Biotechnology Research industry. The company's main headquarters is located in 6650 Lusk Boulevard, Suite B105. Explore DEVACELL, INC.'s company overview page for more information.

What is DEVACELL, INC.'s most common email format?

Minus sign iconPlus sign icon
DEVACELL, INC. employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more DEVACELL, INC. email formats with LeadIQ.

How many employees does DEVACELL, INC. have currently?

Minus sign iconPlus sign icon
DEVACELL, INC. has approximately 5 employees as of December 2025. These team members are located across 1 continents, including North America.

Who are DEVACELL, INC.'s key employees and leadership?

Minus sign iconPlus sign icon

As of December 2025, DEVACELL, INC.'s key employees include:

  • Chief Executive Officer: I. Y.
  • Chief Operating Officer: J. S.
  • R&d Scientist Nano Engineering: M. S.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.